Ocular Disposition of ∆<sup>8</sup>-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations.

导出 OA

翻译打印收藏纠错

第一作者： Nagendra S,Punyamurthula

第一单位： Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.

作者： Nagendra S,Punyamurthula ^[1] ; Goutham R,Adelli ^[1] ; Waseem,Gul ^[2] ; Michael A,Repka ^[3] ; Mahmoud A,ElSohly ^[4] ; Soumyajit,Majumdar ^[5]

作者单位： Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA. ^[1] ElSohly Laboratories Inc., 5-Industrial Park Drive, Oxford, Mississippi, 38655, USA. ^[2] Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.;Research Institute of Pharmaceutical Sciences, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA. ^[3] Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA.;ElSohly Laboratories Inc., 5-Industrial Park Drive, Oxford, Mississippi, 38655, USA.;Research Institute of Pharmaceutical Sciences, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA. ^[4] Department of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA. majumso@olemiss.edu.;Research Institute of Pharmaceutical Sciences, University of Mississippi, 111 Faser Hall, University, Mississippi, 38677, USA. majumso@olemiss.edu. ^[5]

关键词 lipid-based drug delivery ocular drug delivery ocular films solid lipid nanoparticles tetrahydrocannabinol